A PHYSICAL FORM OF N-[4-[5-(CYCLOPENTYLOXYCARBONY)AMINO-1-METHYLINDOL-3YL-METHY1]-3-METHOXYBENZOY1]-2-METHLBENZENESULPHONAMIDE, PROCESSES FOR ITS PREPARATION AND COMPOSITIONS CONTAINING IT
The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxy- carbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxybenzoyl]-2-methyl- benzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and ano...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxy- carbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxybenzoyl]-2-methyl- benzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and another physical form of N-[4-[S-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]- -3-methoxybenzoyl]-2-methylbenzenesulphonamide useful in the preparation of the first mentioned physical form. The compositions are useful in the treatment of diseases in which leukotrienes are implicated, for example asthma. |
---|